HRTX Quote, Trading Chart, Heron Therapeutics Inc.
home / stock / hrtx / hrtx quote
$17.29 Last:
2.01% Change Percent:
$17.25 Open:
$17.29 Previous Close:
$17.55 High:
$16.45 Low:
733,755 Volume:
03/05/2021 03:15:31 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-03-05 | 17.25 | 17.29 | 17.55 | 16.45 | 733,755 |
| 2021-03-04 | 17.2 | 16.95 | 17.55 | 16.51 | 1,128,405 |
| 2021-03-03 | 17.57 | 17.28 | 17.84 | 17.08 | 834,156 |
| 2021-03-02 | 18.01 | 17.68 | 18.21 | 17.66 | 666,868 |
| 2021-03-01 | 18.41 | 18.09 | 18.615 | 17.88 | 838,665 |
| 2021-02-26 | 18.04 | 18.08 | 18.93 | 17.87 | 957,672 |
| 2021-02-25 | 19.16 | 18.05 | 20.45 | 17.93 | 2,207,938 |
| 2021-02-24 | 18.04 | 19.31 | 19.57 | 17.57 | 947,182 |
| 2021-02-23 | 18.18 | 17.86 | 18.4883 | 17.57 | 667,302 |
| 2021-02-22 | 18.81 | 18.4 | 19 | 18.39 | 540,810 |
| 2021-02-19 | 18.2 | 19 | 19.43 | 18.2 | 781,985 |
| 2021-02-18 | 18.47 | 18.18 | 18.77 | 18.13 | 576,274 |
| 2021-02-17 | 18.545 | 18.49 | 18.815 | 18.16 | 744,820 |
| 2021-02-16 | 18.87 | 18.31 | 18.87 | 17.98 | 670,716 |
| 2021-02-15 | 18.48 | 18.34 | 19.03 | 18.22 | 592,191 |
| 2021-02-12 | 18.48 | 18.34 | 19.03 | 18.22 | 591,964 |
| 2021-02-11 | 19.38 | 18.51 | 19.5 | 18.4 | 583,420 |
| 2021-02-10 | 19.76 | 19.34 | 20.03 | 19.04 | 493,260 |
| 2021-02-09 | 19.65 | 19.7 | 19.89 | 19.21 | 618,672 |
| 2021-02-08 | 19.51 | 19.56 | 20.11 | 19.38 | 1,111,657 |
Heron Therapeutics Inc. Company Name:
HRTX Stock Symbol:
NASDAQ Market:
Heron Therapeutics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020 and Highlights Recent Corporate Updates PR Newswire SAN DIEGO , Feb. 24, 2021 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotec...
-
Heron Therapeutics Announces Publication of Results from EPOCH 1 Follow-On Study of HTX-011 in Patients Undergoing Bunionectomy Surgery - 77% of Bunionectomy Patients Receiving HTX-011 Required No Opioids to Manage Their Postoperative Pain Through 72 Hours After Surgery and Cont...
-
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises and Announces New Development Program - Preliminary Full-Year 2020 Net Product Sales for CINV Franchise of Approximately $88.3 Million, versus Guidance of $85 Million - - Full-Year 2021 Net Product...